Banned medicine (Credit-Canva)
The Union Health Ministry implemented a ban on 156 "irrational" FDC medicines, effective immediately. These medicines, including widely used antibiotics, painkillers, and multivitamins, were commonly used to treat fever, cough, and infections. The ban was imposed due to the associated health risks and lack of therapeutic justification for the ingredients in these FDCs.
FDCs or fixed-dosed combinations, also known as "cocktail drugs," are medications that combine multiple drugs in a single pill. They are designed to treat multiple symptoms or conditions simultaneously. While they offer convenience, they can pose significant risks. These risks include the possibility of overdose, adverse interactions between the drugs, and the development of antibiotic resistance. Additionally, many FDC medicines lack sufficient scientific evidence to support their safety and efficacy.
Experts have raised concerns about the use of FDC medicines. They believe that many of these combinations lack sufficient scientific evidence to support their safety and effectiveness. Additionally, the combination of multiple drugs in a single pill can increase the risk of adverse side effects and interactions with other medications.
Experts have also found that FDC medicines may not be as effective as individual drugs in treating certain conditions. It is important to note that safer and more effective alternatives are available for most of the medical conditions that FDC medicines were used to treat. One particular concern is the inclusion of antibiotics in some FDCs. Overuse of antibiotics can contribute to the development of antibiotic resistance, a major public health threat.
The use of FDC medicines can lead to adverse effects, including serious ones. Additionally, safer alternatives, tested in clinical trials, are available to treat the same medical conditions. Experts recommend prescribing drugs individually based on a patient's clinical symptoms rather than combining them in FDCs.
The ban on irrational FDC medicines by the Union Health Ministry can be seen as a positive step towards promoting rational drug use and protecting public health. The goal is to eliminate unnecessary and potentially harmful drug combinations. This is a step forward in reducing the risks associated with medication and ensure safer and more effective treatment options for patients.
Credit: iStock
Amid concerns over the MMR vaccine and falling childhood vaccination rates in the US, another child has died with measles.
The death was confirmed by Lancaster County Coroner Stephen Diamantoni, who said his office was investigating the case. He said the child died “a few weeks ago” but could not confirm whether it was the death Pennsylvania Gov. Josh Shapiro referred to last week.
“We just want to cast as wide a net as possible and identify any deaths that may have occurred in individuals who had measles,” Diamantoni said.
It remains unclear whether this is the second or third measles-associated death reported in the US this year.
In late August, Pennsylvania reported two measles-associated deaths in 2026, both involving unvaccinated individuals. One was reportedly an infant, while details about the second person have not been released.
The deaths are the first measles-related deaths reported in Pennsylvania in 35 years, according to the state Department of Health.
The infant’s death has been disputed. Lancaster County Coroner said the newborn tested positive for measles but died shortly after birth from a lacerated spleen. Measles antibodies were found during postmortem testing.
“The newborn had measles” but did not “die of measles,” Parsons said, citing the coroner.
The CDC has not included the two Pennsylvania deaths in its national measles count while it reviews additional information about the circumstances and causes of death.
According to the CDC, available information does not establish whether measles caused or contributed to the deaths or whether the individuals died from other causes while infected with measles.
The Department of Health and Human Services said the deaths had not been confirmed based on the information available to the CDC.
Pennsylvania, however, maintains that it followed the standard process and provided the CDC with the required epidemiological data.
The state calls the deaths “measles-associated,” meaning there is laboratory or epidemiological evidence of measles, even if the virus is not established as the immediate cause of death.
The US CDC has 2,903 confirmed measles cases in the US in 2026, as of August 27, 2026, the highest number in 35 years.
The cases are spiraling amid anti-vaccine stance promoted by the Trump-led US government and HHS Secretary RFK Jr.
More recently, Trump also announced a split of the MMR vaccine.
Measles has been considered eliminated in the US since 2000, but the Pan American Health Organization is expected to decide in November whether the US has lost its elimination status.
Measles is one of the most contagious infectious diseases. An infected person can spread the virus to around nine out of 10 unvaccinated people exposed to it.
Most people recover, but measles can cause serious complications, including pneumonia, brain inflammation and death.
Infants, pregnant women and people with weakened immune systems are particularly vulnerable.
Early measles symptoms can resemble a common cold and include:
A distinctive sign of measles is the appearance of tiny white spots, called Koplik spots, inside the mouth. These spots typically develop two to three days after the initial symptoms begin. Their presence is an important diagnostic clue and often appears before the characteristic measles rash.
A rash appears three to five days after the initial symptoms. It usually starts as flat, red spots on the face, near the hairline, and then spreads downward to the neck, trunk, arms, legs and feet.
The spots can sometimes be slightly raised and may merge. When the rash appears, the fever may also increase significantly.
Groups at higher risk of measles complications include:
Two doses of the MMR vaccine are key to preventing measles. Te first MMR dose is recommended at 12 to 15 months, followed by a second dose at 4 to 6 years.
Credit: iStock
UK health officials have reported the breeding of an invasive mosquito species known to spread dengue, chikungunya and Zika viruses.
While this is the fourth time Aedes aegypti has been detected in the UK, it is the first time the species has been found breeding. The mosquitoes were found reproducing in homes in east London.
The UK Health Security Agency (UKHSA) said the risk to the public is low, with no evidence of human infections linked to these mosquitoes.
Officials believe the mosquitoes may have been accidentally imported in baggage, vehicles or plants. Measures to destroy larvae, along with surveillance and trapping, have been stepped up.
Mosquito-borne diseases kill more than one million people and infect up to 700 million each year.
While Aedes aegypti mosquitoes are usually found in tropical and subtropical climates, the current risk to the UK public remains low. The species is unlikely to survive long-term in the UK's colder temperatures.
UKHSA head of medical entomology Dr Jolyon Medlock said: "There is no evidence that these mosquitoes have caused human infections and importantly, to date, there is no evidence of the mosquitoes or larvae being detected in nearby public areas."
Dr César López-Camacho of the University of Oxford called the finding "important" but said it was not a reason for alarm.
Despite recent heatwaves, the overall UK climate remains too cold for Aedes aegypti to survive long-term, UKHSA said.
The mosquitoes were detected through the Mosquito Watch scheme, which monitors invasive species.
Medlock said the UK will continue to see invasive mosquitoes and that, as the climate warms, he expects more reports of them surviving.
Globally, dengue cases are increasing across the Western Pacific and Southeast Asia. These increases are fueled by climate change, globalisation and immunological naïveté, alongside the limited impact of existing control measures.
“While the current mosquitoes are unlikely to be infected, and so the risk to people will be low, their presence may indicate a regular summer event in future years. These mosquitoes will not survive the cooler weather of autumn or winter, but new introductions next year may lead to breeding again,” Martin Hibberd, Professor of Emerging Infectious Disease at the London School of Hygiene & Tropical Medicine (LSHTM), said.
He said the mosquitoes live in and around human habitations and are well adapted to city life, requiring the right climate conditions, which the UK is now experiencing more regularly.
Dr Robert Jones, Assistant Professor in the Department of Disease Control at LSHTM, said: “Even in outbreak situations, only a fraction of mosquitoes are infected, so the risk to the public from this finding is very low.”
He advised people to make gardens and outdoor spaces less suitable for mosquitoes by removing standing water.
“Mosquitoes can lay eggs in buckets, containers, plant pots and other places where water accumulates, so removing standing water can help limit the places available for them to lay eggs and reduce the likelihood of populations becoming established.”
To lower your risk of dengue and other mosquito-borne diseases:
Mosquito detection and eradication programs are key to preventing the problem from becoming a bigger public-health risk.
Credit: Massachusetts General Hospital
A pig kidney transplanted into a US man in 2025 functioned in his body for 271 days, marking the longest dialysis-free survival reported following a porcine kidney transplant, according to Harvard Medical School.
Tim Andrews, who was 66 at the time of the xenotransplantation, did not need dialysis for 271 days before receiving a human kidney from a deceased donor.
In January 2025, Andrews, received a genetically edited pig kidney, after being on dialysis for more than two years due to end-stage kidney disease. He became the fourth worldwide to receive a pig kidney.
Andrews received the genetically engineered pig kidney under an FDA Expanded Access Investigational New Drug application.
A team of doctors monitored him for kidney function, rejection, antibody development and potential pig-to-human infection, and found that the kidney began functioning immediately. An early episode of T-cell-mediated rejection resolved with treatment, and no pig pathogen transmission was detected, revealed the case published in the journal The Lancet.
After approximately six months, immunosuppression was reduced because of an infection. The xenotransplant subsequently developed microvascular injury and inflammation that progressed to organ failure.
In January this year Andrews received a deceased-donor human kidney, which showed immediate graft function, with no evidence of sensitization during follow-up.
The findings illustrate both the promise of xenotransplantation and the areas that still need improvement before pig organs can become a broader transplant option.
Importantly, the microvascular injury seen in the porcine kidney has implications for developing immunosuppressive strategies, donor genetic engineering and monitoring approaches in future clinical transplantation studies, the researchers said.
According to the latest data from the Global Observatory on Donation and Transplantation, a record 183,896 solid organ transplants were performed globally across 96 countries. This represents a 4% increase over 2024, primarily driven by an 11% rise in donations after circulatory death (DCD) and a 4% increase in living-donor transplants.
Despite this growth, a 90% unmet need remains a critical global issue as demand continues to rise, driven by chronic conditions such as diabetes and cardiovascular disease.
In the US alone, over 109,000 people remain on the national transplant waiting list, while an average of 12 people die every day waiting for a compatible match, according to HRSA Organ Donor Statistics.
India recorded a record 20,138 transplants, yet more than 89,000 patients are actively waitlisted, according to data from NOTTO. The deceased-donor rate remains critically low at 0.77 per million people, with deceased-donor organs accounting for only 18% of the country's total transplant pool.
“The organ shortage is the greatest crisis we have right now in transplantation,” said Leonardo Riella, associate professor of surgery at Mass General and medical director for kidney transplantation at Mass General Brigham.
“We know that the best treatment option for patients with end-stage kidney disease who have developed renal failure is transplantation, but we simply don’t have enough human organs to transplant in a timely manner.”
Andrews’ case therefore offers a potential way to help bridge this gap.
“Our vision is that xenotransplantation could help address this gap — initially as a bridge to get patients off dialysis while they wait for a human donor kidney, and potentially, as we establish long-term safety and durability, as a destination therapy in its own right,” Riella said.
© $2026 Times Horizon Private Limited